CLOV
Price
$2.53
Change
+$0.01 (+0.40%)
Updated
Dec 24 closing price
Capitalization
1.31B
69 days until earnings call
Intraday BUY SELL Signals
NEUE
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
60.94M
Intraday BUY SELL Signals
Interact to see
Advertisement

CLOV vs NEUE

Header iconCLOV vs NEUE Comparison
Open Charts CLOV vs NEUEBanner chart's image
Clover Health Investments
Price$2.53
Change+$0.01 (+0.40%)
Volume$1.42M
Capitalization1.31B
NeueHealth
PriceLoading...
Change-$0.00 (-0.00%)
Volume$11.97K
Capitalization60.94M
CLOV vs NEUE Comparison Chart in %
CLOV
Daily Signal:
Gain/Loss:
NEUE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLOV vs. NEUE commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Hold and NEUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (CLOV: $2.53 vs. NEUE: $6.75)
Brand notoriety: CLOV and NEUE are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 19% vs. NEUE: 100%
Market capitalization -- CLOV: $1.31B vs. NEUE: $60.94M
CLOV [@Managed Health Care] is valued at $1.31B. NEUE’s [@Managed Health Care] market capitalization is $60.94M. The market cap for tickers in the [@Managed Health Care] industry ranges from $296.73B to $0. The average market capitalization across the [@Managed Health Care] industry is $44.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 1 FA rating(s) are green whileNEUE’s FA Score has 1 green FA rating(s).

  • CLOV’s FA Score: 1 green, 4 red.
  • NEUE’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUE is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 5 TA indicator(s) are bullish while NEUE’s TA Score has 1 bullish TA indicator(s).

  • CLOV’s TA Score: 5 bullish, 2 bearish.
  • NEUE’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, CLOV is a better buy in the short-term than NEUE.

Price Growth

CLOV (@Managed Health Care) experienced а -2.69% price change this week, while NEUE (@Managed Health Care) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -0.36%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was -1.77%.

Reported Earning Dates

CLOV is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Managed Health Care (-0.36% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLOV($1.31B) has a higher market cap than NEUE($60.9M). NEUE YTD gains are higher at: -8.989 vs. CLOV (-19.683). NEUE has higher annual earnings (EBITDA): -21.48M vs. CLOV (-56.85M). CLOV has more cash in the bank: 203M vs. NEUE (146M). CLOV has less debt than NEUE: CLOV (3.67M) vs NEUE (213M). CLOV has higher revenues than NEUE: CLOV (1.77B) vs NEUE (890M).
CLOVNEUECLOV / NEUE
Capitalization1.31B60.9M2,146%
EBITDA-56.85M-21.48M265%
Gain YTD-19.683-8.989219%
P/E RatioN/A1.19-
Revenue1.77B890M199%
Total Cash203M146M139%
Total Debt3.67M213M2%
TECHNICAL ANALYSIS
Technical Analysis
CLOVNEUE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLOV
Daily Signal:
Gain/Loss:
NEUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGREX12.360.07
+0.57%
TCW Global Real Estate I
EARAX16.200.05
+0.31%
Eaton Vance All Asset Strategy A
MEMFX38.320.03
+0.08%
MFS Emerging Markets Equity R2
BTSMX24.94N/A
N/A
Boston Trust SMID Cap
VVIIX14.05N/A
N/A
VOYA VACS Index Series I Portfolio

CLOV and

Correlation & Price change

A.I.dvisor tells us that CLOV and OSCR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLOV and OSCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
+0.40%
OSCR - CLOV
27%
Poorly correlated
+0.61%
CVS - CLOV
25%
Poorly correlated
+1.38%
CNC - CLOV
25%
Poorly correlated
+0.73%
NEUE - CLOV
24%
Poorly correlated
N/A
ELV - CLOV
23%
Poorly correlated
+0.02%
More

NEUE and

Correlation & Price change

A.I.dvisor tells us that NEUE and PGNY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEUE and PGNY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUE
1D Price
Change %
NEUE100%
N/A
PGNY - NEUE
24%
Poorly correlated
-0.23%
CLOV - NEUE
24%
Poorly correlated
+0.40%
CVS - NEUE
21%
Poorly correlated
+1.38%
UNH - NEUE
21%
Poorly correlated
+0.86%
CI - NEUE
21%
Poorly correlated
+0.41%
More